A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

Clinical trial NCT06592638 · RECRUITING

Trial details

NCT number: NCT06592638
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2025-03-31
Primary completion: 2026-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.